Collectively, these findings demonstrate that muscle expression and circulating levels of Musclin are increased in cases of obesity and diabetes in both humans and mice, and that Musclin might play a pivotal role in the pathogenesis of obesity and its associated metabolic disorders through crosstalk between muscles and other metabolic tissues. This evidence concerns the gene OSTN and metabolic disease.